List/tripsitting
Psychedelic tripsitting
-
Psychological first aid
-
Long-term depression treatment
-
Neuroaesthetics
-
Invariant addiction treatment
-
Antidotes
- Anticonvulsants/antiepileptics: Common
- Antipsychotics: Common
- Anxiolytics: Common
- Hydroxyzine (for paranoia along with antipsychotic mechanisms)
- Serotonin syndrome treatment: Common
Dissociative tripsitting
-
Psychological first aid
-
Invariant short-term depression treatment
Deliriant tripsitting
-
Antidotes
- Physostigmine (for diphenhydramine overdose)
Cannabinoid tripsitting
-
Psychological first aid
-
Humor varieties
-
Antidotes
- CBD (non-inhalant ROA): Firstly: Vaped or smoked CBD heated to 250-300 C will partially be converted to THC.[1] Thus it's inconvenient to smoke or vape CBD to relieve a THC toxicity. Secondly: 50 times more CBD than THC is needed to reduce acute effects of THC,[2] which makes it practically impossible to administer proper dosage by inhalation. Also, the quantity of CBD converted into THC will increase a lot with the required ratio, and excessive harshness in the lungs may escalate a bad trip.
Miscellaneous hallucinogen tripsitting
Depressant tripsitting
-
Antidotes
- Atropine (for nerve agent poisoning)
- N-acetylcysteine (for acetaminophen overdose)
-
GABAergic tripsitting
Invariant anxiety treatment
- Anticonvulsants/antiepileptics: Common
- Flumazenil (for benzodiazepine overdose)
-
Opioid tripsitting
Stimulant tripsitting
-
Dealing with stimulant psychosis
- Cautionary note: the combination of being on dopaminergic agonists and attempting to stop their effects with dopaminergic antagonists may result in a life-threatening condition known as neuroleptic malignant syndrome.
Entactogen tripsitting
-
PTSD treatment
- ❌ MDMA Therapy: US FDA rejects that this is an effective treatment option.
-
Antidotes
- Serotonin syndrome treatment: Common
- ↑ Czégény, Z; Nagy, G; Babinszki, B; Bajtel, Á; Sebestyén, Z; Kiss, T; Csupor-Löffler, B; Tóth, B; Csupor, D (26 April 2021). "CBD, a precursor of THC in e-cigarettes". Scientific reports. 11 (1): 8951. doi:10.1038/s41598-021-88389-z. PMC 8076212 Check
|pmc=
value (help). PMID 33903673. - ↑ Englund, A., Oliver, D., Chesney, E., Chester, L., Wilson, J., Sovi, S., De Micheli, A., Hodsoll, J., Fusar-Poli, P., Strang, J., Murray, R. M., Freeman, T. P., McGuire, P. (16 November 2022). "Does cannabidiol make cannabis safer? A randomised, double-blind, cross-over trial of cannabis with four different CBD:THC ratios". Neuropsychopharmacology: 1–8. doi:10.1038/s41386-022-01478-z. ISSN 1740-634X. Retrieved 25 November 2022.